Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 02/2020
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

NEW ON THE MARKET
Me too: rifamycin (RELAFALK) against traveller's diarrhea
LARYNGOMEDIN OCTENIDIN ANTISEPT against sore throat

THERAPY FROM A CRITICAL VIEWPOINT
Stress ulcer prophylaxis with proton pump inhibitors: what's new?

a-t READER'S QUESTIONS AND COMMENTS
QT prolongation: is escitalopram better than citalopram?

BEWARE MISINFORMATION
Dasatinib (e.g. SPRYCEL): for chronic myelogenous leukaemia only the original preparation?

IN BRIEF
Rivaroxaban as antithrombotic therapy after transcatheter aortic-valve replacement (TAVI): more harm than benefit
Sunscreen: benefit documented, risks of absorbed UV filters remains unclear

CURRENT ADR NETWORK REPORT
Severe allergic reaction with flurbiprofen lozenges (e.g. DOBENDAN DIREKT)

SIDE EFFECTS
Xylometazoline nasal drops risk of incorrect dosing in infants
Impulse control disorders with selective serotonin reuptake inhibitors (SSRIs)  free article 
Panic attacks with levonorgestrel-releasing intrauterine devices (e.g. MIRENA)

e a-t ON THE INTERNET
Larotrectinib (VITRAKVI) for solid tumours
© 2020 arznei-telegramm